MMR and autism: Italy's courts get involved
An Italian health news website seems to have reported that an Italian court has ruled that an MMR vaccine caused autism in a child.
First 'cross-kingdom' vax effective in PhI
NovaDigm Therapeutics is developing a vaccine that could work against both bacteria and fungi, and could even combat resistant bacteria such as MRSA. The company presented Phase I results at the 15th Annual Conference on Vaccine Research.
Study: Further insight into Merck HIV vax infection increase
A recent study published in the Journal of Infectious Disease confirmed that a vaccine study halted in 2007 showed an increased risk of infection in the first 18 months for subgroups of the men who were vaccinated, but that this difference disappeared after 18 months.
Pneumococcal vax cuts deaths, but cases tripled
While vaccines against Streptococcus pneumoniae have cut the number of deaths from this bug that can cause pneumonia and meningitis, the number of cases has tripled in the past 50 years.
Swine flu vax could offer universal flu protection
Researchers in Canada are touting a 2009 swine flu shot as a potential route to a universal vaccine that could target all forms of influenza, according to data published in Frontiers of Immunology.
Red cedar allergy DNA vax hits the clinic
Immunomic Therapeutics is developing a DNA plasmid-based allergy vax for this allergy, code-named JRC-LAMP-vax, and has been cleared by the U.S. FDA to begin a Phase I clinical trial in Atlanta in June 2012.
UPDATED: Teen meningitis B vax successful in Phase II
A team from Australia has shown positive immune responses in a Phase II trial of Pfizer's meningitis B vaccine in teenagers.
Ampligen-FluMist nasal trial begins
Hemispherx Biopharma's RNA-based adjuvant, Ampligen (rintatolimod), is being tested in a new indication--this time intranasally for the first time in humans along with AstraZeneca's nasal flu vaccine FluMist.
Mucosis nasal flu vaccine shows positive results in animals
Preclinical data published in Vaccine on Dutch biotech Mucosis' nasal flu vaccine showed that it protected mice against infection with the flu virus.
Bird flu vaccine hits the clinic
Novavax saw a climb in its share value on the announcement that it has started enrollment of a Phase I clinical trial of its A/H5N1 vaccine to prevent bird flu.
'Designer' lymph nodes could boost cancer vaccines
Researchers at the Moffitt Cancer Center are developing "designer" lymph nodes that could be used to boost the effects of cancer vaccines.
Japan OKs Sanofi's inactivated polio vaccine
Japan has granted marketing approval for its first inactivated polio vaccine (IPV), Sanofi's Imovax Polio, and will begin using the vaccine in public immunization programs beginning Sept. 1.
GSK's Nimenrix gets green light in Europe
GlaxoSmithKline's meningitis vaccine Nimenrix has been granted approval in Europe by the Committee for Medicinal Products for Human Use (CHMP).
Celebrating vaccines: World Immunization Week 2012
The World Health Organization has declared this week to be World Immunization Week.
Nigeria commits to AIDS vaccine development
In Nigeria, around 3.3 million people were living with HIV/AIDS in 2010. To try to combat this, the country is kick-starting its vaccine program again.
'Hypervirulent' salmonella could overwhelm a vaccine
Researchers in the U.S. and Australia have found that salmonella bacteria have the capacity to overwhelm vaccines.
Army researcher develops microemulsion vaccine carrier
A microemulsion vaccine carrier, developed by U.S. Army Maj. Jean M. Muderhwa and presented at Experimental Biology 2012, has the potential to improve the stability of vaccines.
New DCVax-L brain cancer vaccine trial starts enrolling
Another site in the U.S. has begun recruiting for a Phase II clinical trial of Northwest Biotherapeutics' DCVax-L personalized brain cancer vaccine for the treatment of glioblastoma multiforme.
Txt msg reminders swell flu vaccine uptake--gr8!
In the first large, population-based randomized controlled trial of the effectiveness of text message vaccine reminders, parents getting a reminder were more likely to take their kids for a flu shot.
Shingles shot safe and well-tolerated, study finds
Shingles can lead to post-herpetic pain and other issues in older people, and the vaccine, which halves the chance of severe attacks of shingles, is safe and well-tolerated in this group, a new study finds.
Latest Commentary